Food and Drug Policy Forum

FDLI's Food and Drug Policy Forum provides a marketplace for the exchange of policy ideas regarding food and drug law issues, and is complimentary to all FDLI Members. The Policy Forum articles are on cutting-edge state, national and international policy issues related to food and drug law.

The Policy Forum is published biweekly (24 times a year) and is provided as a complimentary benefit to FDLI members, and by subscription to members of associations on the Forum Editorial Advisory Board (listed below) and non-members. Individual issues of the Policy Forum are also available for separate purchase.



Food and Drug Policy Forum

In the Aftermath of Parens Patriae: Can Private Copycats Still Sue?

April 2013

This issue of our Policy Forum (Volume 3, Number 8, April 24, 2013) — In the Aftermath of Parens Patriae: Can Privat...

Substantial Equivalence Under the Family Smoking Prevention and Tobacco Control Act of 2009: How Can FDA Create a More Effective and Efficient Regulatory Scheme?

April 2013

(A Response to Mark E. Greenwold’s ‘What Standards Should FDA Apply in Ruling on Applications for Substantial Equivalence for...

Biosimilar Naming: How Do Adverse Event Reporting Data Support the Need for Distinct Non-Proprietary Names for Biosimilars?

March 2013

This issue of Policy Forum (Volume 3, Number 6, March 27, 2013) – Biosimilar Naming: How Do Adverse Event Reporting Data Suppo...

Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health?

March 2013

In this issue of our Policy Forum (Volume 3, Number 5, March 13, 2013) – Out on a Limb: How Will the Prohibition of Biomedical Rese...

What is the Best Way for Manufacturers and Physicians to Apply Sunscreen to Avoid Being Burned by the Final Sunshine Act Regulations?

February 2013

This issue of Policy Forum (Volume 3, Number 4, February 27, 2013) explains the requirements under the Patient Protection and A...

Additional Policy Forum Details

The Policy Forum welcomes articles on cutting-edge state, national and international policy issues related to food and drug law. FDLI's Food and Drug Policy Forum is designed to provide a venue for the presentation of information, analysis and policy recommendations in these areas: food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

Each 10-page, peer-reviewed issue of the Policy Forum presents an important policy topic in the form of a question, provides background information and detailed discussion of the issues involved in the policy question, relevant research, pertinent sources and policy recommendations.

The 24-member Food and Drug Policy Forum Editorial Advisory Board, comprised of 8 representatives of leading associations interested in food and drug law issues and 16 individuals, provides peer review and guidance on articles considered for publication in the Forum.

  • American Enterprise Institute
  • Consumer Healthcare Products Association
  • Drug Information Association
  • International Dairy Foods Association
  • Medical Device Manufacturers Association
  • Personal Care Products Council
  • PhRMA
  • United Fresh Produce Association